Additionally, a derivative of triptolide (5R)-5-hydroxytriptolide downregulated the expression of (p)-IκB, a major regulator of the RANKL-signaling pathway in RA patients' peripheral blood and synovial fluid [69]. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.